Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Cros Nt Group To Attend Third Annual Oncology Clinical TrialsCROS DE will represent the CROS NT Group at the event in Munich which will discuss challenges and technological strategies for clinical trials in oncology.
By: CROS NT Group Thomas Zwingers, Scientific Director for CROS DE, will be attending the event and brings over 20 years of experience working in clinical trials. Zwingers is the oncology clinical trial specialist for the CROS NT Group. Also attending the event from CROS DE will be Frank Freischläger, Vice President, and Gudrun Skiba, Business Development Manager. With oncology being one of the fastest growing therapeutic areas in the pharmaceutical industry in terms of market size, the Clinical Trials event will focus on “innovative approaches to overcoming the practical challenges of clinical trials in oncology”. The Clinical Trials in Oncology will be attended by leading pharmaceutical and biotechnology companies who will give case study presentations and lead panel and roundtable discussions. The event will particularly focus on innovative technologies during Phase I-III and strategies to expedite and improve efficiency during trial setup. For more information on the Third Annual Oncology Clinical Trials, visit http://www.clinicaltrialsevents.com/ CROS NT will have a booth present in the Exhibitor Room, so please come visit the CROS DE team at Booth #11 during the event. # # # CROS NT Group, an international Contract Research Organisation (CRO), with headquarters in Verona, Italy, has built a strong heritage in biostatistics as well as providing clinical data management, medical communication, pharmacovigilance, and technology solutions to the life science industry for over 18 years. Founded in 1992, CROS NT is well-established in delivering quality, timely delivery, and cost effective service. The Arithmos branch of CROS NT provides IT solutions to the pharmaceutical and biotechnology industries such as hosting, ePRO & eCRF and Project and Portfolio Management to increase the success rate of clinical trials and drug safety development processes. End
|